HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study.
Altice, Frederick L MD, MA *; Bruce, R Douglas MD, MA, MSc *; Lucas, Gregory M MD, PhD +; Lum, Paula J MD, MPH ++; Korthuis, P Todd MD, MPH [S]; Flanigan, Timothy P MD ||; Cunningham, Chinazo O MD, MPH [P]; Sullivan, Lynn E MD *; Vergara-Rodriguez, Pamela MD **; Fiellin, David A MD *; Cajina, Adan MS ++; Botsko, Michael MSW, MPhil ++++; Nandi, Vijay MPH [S][S]; Gourevitch, Marc N MD, MPH ||||; Finkelstein, Ruth ScD [S][S]; the BHIVES Collaborative [P][P]
JAIDS Journal of Acquired Immune Deficiency Syndromes.
56 Supplement 1, Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care:S22-S32, March 1, 2011.
(Format: HTML, PDF)